Hawai?i health equity research and outreach network (hawai?i heron)
Active Cooperative Agreement Awarded Last action
- Award ID
- U01FD007974
- Recipient
-
The Queen's Medical Center UEI YLMUFAJEZPP6
- Awarding agency
-
FDA Office of Acquisition and Grant Services
Food and Drug Administration, Department of Health and Human Services
- Obligated
- $6,023,056
Award facts
- Assistance listing
- 93.103 Food and Drug Administration Research
- Completion date 68% complete
- Originally
- Funding agency
- Office of the Commissioner Food and Drug Administration, Department of Health and Human Services
- Place of performance
- Honolulu, HI 96813, USA
Award details come from USAspending.gov.
Description
- Abstract
- IT is striking and disheartening that asian americans, native hawaiians, and other pacific islanders (AA-nhpi) experience health disparities that are substantial, growing, and poorly understood. Our project entitled "hawai'i health equity research and outreach network (hawai'i heron)" will create an administrative core to allow US to quickly respond and participate in multi-institutional studies that support three health equity pillars: equity of voices, equitable data efforts, and equity in clinical trials. First, we will enhance equity of voices by 1) amplifying the voices of our AA-nhpi stakeholder communities; 2) understanding diverse patient perspectives, preferences, and unmet needs; and 3) supporting expansion of culturally and linguistically tailored health education. Second, we will support equitable data efforts by expanding capacity to evaluate outcomes by 1) race/ethnicity; 2) geography; and 3) other social determinants of health. Third, we will promote equity in clinical trials by 1) identifying barriers; 2) employing innovative strategies to increase clinical trial enrollment for AA-nhpi; 3) understanding the impact of the evolving multicultural landscape on trial participation; and 4) increasing training for diverse students and investigators. The hawai'i heron administrative core will foster collaboration with the food and drug administration office of minority health and health equity and other institutions that are part of the racial & ethnic minority acceleration consortium for health equity (reach) network. In addition, we will leverage the administrative core to conduct a pilot study involving a discrete choice experiment examining AA- nhpi perceptions and preferences for diabetes medications. We will gain an understanding of AA-nhpi preferences regarding attributes of diabetes medications through administering patient preference surveys to 50 AA and 50 nhpi with type 2 diabetes. Random utility theory will serve as the basis for analysis. This assumes that individuals make choices to maximize their utility (or wellbeing), which they derive from different choices. Mixed logit regression, which allows for heterogeneity in preferences across individuals, will be used to estimate the random utility models. Results will enable US to better understand the importance of different attributes and levels, as well as willingness to trade-off between attributes. We will compare findings for AA to those of nhpi and describe similarities and differences. Sensitivity analysis will be used to test the robustness of the results to different assumptions and model specifications. We will hire and train a health equity fellow to support the discrete choice experiment in diabetes medications and build expertise and scholarship for future work and engagement. Achievement of these aims will enable hawai'i heron to be an active partner to the FDA office of minority health and health equity in collaborative research efforts to advance minority health and health equity focused research, to improve outreach and communications, and to support training and mentoring of diverse students and junior researchers.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $0 | |
| Amendment | $100,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $295,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $295,000 | |
| Amendment | $100,000 | |
| Amendment | $100,000 | |
| Amendment | $450,000 | |
| Amendment | $450,000 | |
| Amendment | $450,000 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $0 | |
| Amendment | $50,000 | |
| Amendment | $50,000 | |
| Amendment | $50,000 | |
| Amendment | $50,000 | |
| Amendment | $50,000 | |
| Amendment | $307,000 | |
| Amendment | $307,000 | |
| Amendment | $307,000 | |
| Amendment | $307,000 | |
| Amendment | $307,000 | |
| Amendment | $499,514 | |
| Amendment | $499,514 | |
| Amendment | $499,514 | |
| Original award | $499,514 |
Show all 31
Quick answers
Who received award U01FD007974?
U01FD007974 was awarded to The Queen's Medical Center by FDA Office of Acquisition and Grant Services (Food and Drug Administration) on June 1, 2023.
How much is award U01FD007974 worth?
$6,023,056 has been obligated on U01FD007974.
Which agency awarded U01FD007974?
FDA Office of Acquisition and Grant Services (Food and Drug Administration) awarded U01FD007974, with funding from Office of the Commissioner (Food and Drug Administration).
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award